June 2021

Located in Cherlapally, Hyderabad, India, Sunrise International Labs Ltd is a 100% wholly owned subsidiary of Perdaman Pharmaceuticals Pvt Ltd, a company that specialise in the manufacture and export of various pharmaceutical product formulations such as tablets, capsules, liquid orals and sachets.  Established in 1993, Sunrise International Labs Ltd is well known for its expertise in drug delivery systems, and has continued to expand its varied product portfolio over the decades, covering a wide range of

Syngene International Ltd. is an innovation-focused global discovery, development and manufacturing organization providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries around the world. Syngenes clientele includes world leaders such as Bristol-Myers Squibb, Baxter, Amgen, GSK, Merck KGaA and Herbalife.

Established during the Swadeshi Movement of India, Biological E. Limitedstarted during a time when the nation sought access to critical healthcare products. Founded and led by Dr. DVK Raju, Biological E. Limited commenced its operations in 1953 as a biological products company manufacturing liver extracts and anti-coagulants.  With an objective of transitioning from treating diseases to preventing them, Biological E.

Mayo Clinic researchers and colleagues at the University of Minnesota showed that COVID-19 exacerbates the damaging impact of senescent cells in the body. In preclinical studies, the senolytic drugs discovered at Mayo significantly reduced inflammation, illness, and mortality from COVID infection in older mice. The findings appear in the journal Science.

Scientists working to understand the cellular processes linking high cholesterol to breast cancer recurrence and metastasis report that a byproduct of cholesterol metabolism causes some cells to send out cancer-promoting signals to other cells. These signals are packaged in membrane-bound compartments called extracellular vesicles.

Reported in the journal Endocrinology, the discovery could lead to the development of new anti-cancer therapies, researchers say.

Abbott announced it has received CE Mark and Health Canada approval for its Amplatzer™ Steerable Delivery Sheath, which is used with the company's market-leading Amplatzer Amulet™ Left Atrial Appendage (LAA) Occluder. Now available in Europe and Canada, the new device is the first steerable delivery sheath that has been developed specifically for minimally invasive LAA occlusion (or closure) procedures to treat patients diagnosed with atrial fibrillation who are at risk of ischemic stroke.

“It is a piece of misinformation that subsequent waves of the COVID-19 pandemic are going to cause severe illness in children. There is no data - either from India or globally - to show that children will be seriously infected in subsequent waves.” This was informed by Director, All India Institute of Medical Sciences (AIIMS) Delhi, Dr. Randeep Guleria, during a media briefing on COVID-19, held at National Media Centre, PIB Delhi today.

Employees State Insurance Corporation of India is an integrated social security system tailored to provide social protection to workers,immediate dependent or family, in the organised sector, in contingencies, such as, sickness, maternity and death or disablement due to an employment injury or occupational hazard. The ESI Scheme is mainly financed by contributions raised from employees covered under the scheme and their employers, as a fixed percentage of wages.